Are These Healthcare Stocks Top Takeover Targets?
Following Gilead Sciences' (NASDAQ: GILD) decision to buy Kite Pharma (NASDAQ: KITE) for $11.9 billion in cash, we couldn't help but wonder what other healthcare stocks could be takeover targets, too.
In this episode of The Motley Fool's Industry Focus Healthcare podcast, contributor Todd Campbell joins host Kristine Harjes to discuss how Juno Therapeutics' (NASDAQ: JUNO) pursuit of a safer CAR-T cancer drug could make it a merger and acquisition target and how Mazor Robotics' (NASDAQ: MZOR) robots are disrupting spine surgery and catching Medtronic's (NYSE: MDT) eye in the process.
A full transcript follows the video.
Source: Fool.com
Teva Pharmaceutical Industries Ltd ADR Aktie
30,10 €
0,00 %
Einzigartige Zustimmung für Teva Pharmaceutical Industries Ltd ADR mit ausschließlich Buy-Einschätzungen.
Ein positives, wenn auch bescheidenes, Potenzial für Teva Pharmaceutical Industries Ltd ADR mit einem Kursziel von 34 € im Vergleich zum aktuellen Kurs von 30.1 €.
